CASI Pharmaceuticals, Inc. (CASI) has 35 open-market insider trades by 11 insiders since 2013. The most active filer is Wei-Wu He, CEO & Chairman.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Wei-Wu He | CEOChairman | — | 19 | $61.8M | 2022-06-15 |
| IDG-Accel China Growth Fund GP III Associates Ltd. | Dir10% Owner | — | 2 | $24.7M | 2018-03-21 |
| Sparkle BYTE Ltd. | 10% Owner | — | 1 | $8.9M | 2016-06-24 |
| James Huang | Dir | — | 4 | $2.3M | 2022-09-08 |
| Spectrum Pharmaceuticals Inc. | 10% | — | 3 | $44K | 2017-12-22 |
| Larry Zhang | Pres | — | 1 | $38K | 2020-07-22 |
| Spectrum Pharmaceuticals Cayman, L.P. | 10% | — | 2 | $29K | 2019-04-02 |
| Weihao Xu | CFO | — | 1 | $15K | 2020-12-17 |
| Cynthia W. Hu | COOSecretary | — | 1 | $12K | 2019-01-14 |
| Ken Keyong Ren | Dir | — | 1 | $11K | 2016-01-19 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| James Huang | Director | Buy | $304K | 2022-09-06 |
| James Huang | Director | Buy | $233K | 2022-08-31 |
| James Huang | Director | Buy | $315K | 2022-08-24 |
| James Huang | Director | Buy | $1.4M | 2022-08-19 |
| Wei-Wu He | CEO & Chairman | Buy | $380K | 2022-06-13 |
| Wei-Wu He | CEO & Chairman | Buy | $394K | 2021-11-17 |
Companies that share insiders with CASI, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| Wei-Wu He | CEO & Chairman | Buy | $614K | 2021-08-18 |
| Wei-Wu He | CEO & Chairman | Buy | $12.3M | 2021-03-26 |
| Weihao Xu | CFO | Buy | $15K | 2020-12-16 |
| Wei-Wu He | CEO & Chairman | Buy | $976K | 2020-11-20 |
| Larry Zhang | President | Buy | $38K | 2020-07-22 |
| Wei-Wu He | CEO & Chairman | Buy | $13.5M | 2020-07-22 |
| Wei-Wu He | CEO & Chairman | Buy | $389K | 2020-05-19 |
| Wei-Wu He | CEO & Chairman | Buy | $1.6M | 2020-05-15 |
| Wei-Wu He | Chairman | Buy | $14K | 2020-03-27 |